20-761203-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_033409.4(SLC52A3):​c.1233T>C​(p.Ser411Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.713 in 1,558,282 control chromosomes in the GnomAD database, including 397,953 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 35962 hom., cov: 35)
Exomes 𝑓: 0.72 ( 361991 hom. )

Consequence

SLC52A3
NM_033409.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.24

Publications

23 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 20-761203-A-G is Benign according to our data. Variant chr20-761203-A-G is described in ClinVar as Benign. ClinVar VariationId is 262230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.72 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC52A3NM_033409.4 linkc.1233T>C p.Ser411Ser synonymous_variant Exon 5 of 5 ENST00000645534.1 NP_212134.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC52A3ENST00000645534.1 linkc.1233T>C p.Ser411Ser synonymous_variant Exon 5 of 5 NM_033409.4 ENSP00000494193.1

Frequencies

GnomAD3 genomes
AF:
0.685
AC:
104196
AN:
152114
Hom.:
35935
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.636
Gnomad AMI
AF:
0.778
Gnomad AMR
AF:
0.621
Gnomad ASJ
AF:
0.697
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.739
Gnomad FIN
AF:
0.751
Gnomad MID
AF:
0.718
Gnomad NFE
AF:
0.726
Gnomad OTH
AF:
0.678
GnomAD2 exomes
AF:
0.681
AC:
112365
AN:
165046
AF XY:
0.687
show subpopulations
Gnomad AFR exome
AF:
0.619
Gnomad AMR exome
AF:
0.600
Gnomad ASJ exome
AF:
0.706
Gnomad EAS exome
AF:
0.525
Gnomad FIN exome
AF:
0.733
Gnomad NFE exome
AF:
0.715
Gnomad OTH exome
AF:
0.683
GnomAD4 exome
AF:
0.716
AC:
1006058
AN:
1406048
Hom.:
361991
Cov.:
77
AF XY:
0.717
AC XY:
497785
AN XY:
694290
show subpopulations
African (AFR)
AF:
0.629
AC:
20085
AN:
31924
American (AMR)
AF:
0.608
AC:
22518
AN:
37034
Ashkenazi Jewish (ASJ)
AF:
0.703
AC:
17754
AN:
25262
East Asian (EAS)
AF:
0.473
AC:
17208
AN:
36408
South Asian (SAS)
AF:
0.732
AC:
58585
AN:
80000
European-Finnish (FIN)
AF:
0.737
AC:
35588
AN:
48310
Middle Eastern (MID)
AF:
0.686
AC:
3237
AN:
4722
European-Non Finnish (NFE)
AF:
0.729
AC:
789893
AN:
1084214
Other (OTH)
AF:
0.708
AC:
41190
AN:
58174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
17733
35466
53198
70931
88664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19762
39524
59286
79048
98810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.685
AC:
104278
AN:
152234
Hom.:
35962
Cov.:
35
AF XY:
0.685
AC XY:
50974
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.636
AC:
26444
AN:
41558
American (AMR)
AF:
0.622
AC:
9516
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.697
AC:
2418
AN:
3470
East Asian (EAS)
AF:
0.519
AC:
2675
AN:
5156
South Asian (SAS)
AF:
0.739
AC:
3570
AN:
4830
European-Finnish (FIN)
AF:
0.751
AC:
7967
AN:
10612
Middle Eastern (MID)
AF:
0.724
AC:
213
AN:
294
European-Non Finnish (NFE)
AF:
0.726
AC:
49337
AN:
67990
Other (OTH)
AF:
0.677
AC:
1430
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1761
3522
5284
7045
8806
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.698
Hom.:
59234
Bravo
AF:
0.673
Asia WGS
AF:
0.609
AC:
2118
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser411Ser in exon 5 of SLC52A3: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 73.41% (6372/8680) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://ex ac.broadinstitute.org; dbSNP rs910857).

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Brown-Vialetto-van Laere syndrome 1 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Progressive bulbar palsy of childhood Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
12
DANN
Benign
0.73
PhyloP100
1.2
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs910857; hg19: chr20-741847; COSMIC: COSV54077188; API